Showing results (171-180 of 252) with videos related to

Sort By:
Pageof 26
Pharmacological Research|January 8, 2016
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting systemConcetta Rafaniello, Carmen Ferrajolo, Maria Giuseppa Sullo, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Synthesis of N-substituted-N-acylthioureas of 4-substituted piperazines endowed with local anaesthetic, antihyperlipidemic, antiproliferative activities and antiarrythmic, analgesic, antiaggregating actionsAngelo Ranise, Andrea Spallarossa, Olga Bruno, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 5, 2019
Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in DenmarkDaniel Bech Rasmussen, Uffe Bodtger, Morten Lamberts, et al.
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Retrospective Analysis of a Real-Life Use of Tixagevimab-Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19Nicolina Capoluongo, Annamaria Mascolo, Francesca Futura Bernardi, et al.
Journal of Child and Adolescent Psychopharmacology|December 14, 2012
Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring studySimona Ruggiero, Concetta Rafaniello, Carmela Bravaccio, et al.
Pharmacological Reports : PR|April 8, 2025
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance dataNunzia Balzano, Raffaella Di Napoli, Federica Fraenza, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 2, 2020
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitorsMarzia Del Re, Ron H N van Schaik, Stefano Fogli, et al.
European Journal of Pharmacology|July 27, 2025
Real-world safety comparison of liraglutide and semaglutide in weight management: Insights from European pharmacovigilance dataRosanna Ruggiero, Miriam Longo, Annamaria Mascolo, et al.
European Child & Adolescent Psychiatry|July 4, 2020
Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings: a meta-analysis and meta-regressionMarco Pozzi, Roberta Ida Ferrentino, Giulia Scrinzi, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration CriteriaValerio Liguori, Alessia Zinzi, Mario Gaio, et al.
Pageof 26